Original Query: ALL
Previous Study | Return to List | Next Study

Everolimus/Sorafenib or Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01616186
Recruitment Status : Withdrawn
First Posted : June 11, 2012
Last Update Posted : April 8, 2013
Information provided by (Responsible Party):
Andrea Harzstark, University of California, San Francisco

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : December 2015
  Estimated Study Completion Date : April 2016